Filing Details
- Accession Number:
- 0001437749-24-028990
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-11 17:49:22
- Reporting Period:
- 2024-09-09
- Accepted Time:
- 2024-09-11 17:49:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 768408 | Cyanotech Corp | CYAN | Medicinal Chemicals & Botanical Products (2833) | 911206026 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1201156 | / A Michael Davis | Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy #102 Kailua-Kona HI 96740 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Cyanotech Corporation Common Stock | Acquisiton | 2024-09-09 | 5,000 | $0.84 | 1,318,773 | No | 4 | P | Indirect | By self as trustee of the Michael Arlen Davis Revocable Trust |
| Cyanotech Corporation Common Stock | Acquisiton | 2024-09-10 | 5,000 | $0.83 | 1,323,773 | No | 4 | P | Indirect | By self as trustee of the Michael Arlen Davis Revocable Trust |
| Cyanotech Corporation Common Stock | Acquisiton | 2024-09-10 | 66,667 | $0.75 | 1,390,440 | No | 4 | A | Indirect | By self as trustee of the Michael Arlen Davis Revocable Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By self as trustee of the Michael Arlen Davis Revocable Trust |
| No | 4 | P | Indirect | By self as trustee of the Michael Arlen Davis Revocable Trust |
| No | 4 | A | Indirect | By self as trustee of the Michael Arlen Davis Revocable Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Cyanotech Corporation Common Stock | 12,119 | Direct | |
| Cyanotech Corporation Common Stock | 31,250 | Indirect | By Spouse |
| Cyanotech Corporation Common Stock | 150,000 | Indirect | By self as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust |
| Cyanotech Corporation Common Stock | 58,000 | Indirect | By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust |
| Cyanotech Corporation Common Stock | 58,789 | Indirect | By self as trustee for Nyracai Johnstone Davis GST Exempt Trust |
Footnotes
- Adoption date of referenced 10b5-1(c) plan is: 03-06-2024
- To reduce the Company's ongoing cash expense, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his quarterly director fees in the form of restricted stock in lieu of cash. The Reporting Person elected to receive shares of restricted stock in lieu of cash for the fourth quarter of fiscal 2023, the first quarter of fiscal 2024, the third quarter of fiscal 2024, the fourth quarter of fiscal 2024 and the first quarter of fiscal 2025.
Billionaire Hedge Funds
